Form 4: AbbVie Director Roxanne S. Austin Reports Stock Award and Disposal

Director Roxanne S. Austin reports acquisition of restricted stock units and disposal of common stock.

Summary

• On May 9, 2025, Roxanne S. Austin, a director of AbbVie Inc., reported a transaction involving AbbVie's common stock.
• Austin acquired 1,203 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These restricted stock units will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
• Austin also disposed of 38,458 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock upon the earlier of the director's separation from service, death, or a change in control.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It assures stakeholders that insider transactions are being monitored and disclosed as required by regulations.

Key Dates

Keywords

AbbVie, Director, Stock, Restricted Stock Units, Form 4, Beneficial Ownership, ABBV, Incentive Stock Program